WEDNESDAY, JANUARY 18, 2023 (HealthDay News) — A web-based system is effective in diagnosing and treating recurrent benign paroxysmal positional vertigo (BPPV), announced online Jan. 17. According to research, Department of Neurology, JAMA.
Dr. Hyo-Jung Kim and colleagues at Seoul National University Bundang Hospital, South Korea, investigated the efficacy of web-based diagnosis and treatment of BPPV in the event of relapse in a cohort of 585 patients diagnosed and treated with BPPV. examined gender. Patients were randomly assigned to treatment or control groups in a 1:1 ratio (292 and her 293 participants, respectively). The treatment group completed a questionnaire for diagnosis and video clips for self-administration of the canalicular repositioning maneuver (CRM) when experiencing positional vertigo again, depending on the type of her BPPV diagnosed. received. Patients in the control group received video clips for CRM self-administration based on her BPPV type diagnosed at enrollment.
The researchers found that 128 patients (21.9%) had a relapse (58 and 70 in the treatment and control groups, respectively). 109 people have successfully used his web-based system. In the intention-to-treat analysis, 72.4% and 42.9% of the participants in the treatment and control groups, respectively, reported resolution of dizziness.
“This randomized, multicenter trial demonstrated the efficacy of a web-based diagnostic and treatment system for recurrent BPPV,” the authors wrote. “Moreover, most patients were able to successfully use the system even when recurrence of BPPV was presumed.”
Several authors disclosed financial ties to DZMED.
Abstract/Full Text (subscription or payment may be required)
Copyright © 2023 HealthDay. All rights reserved.
